GLOW Stack

Wolverine + GHK-Cu — 'take the Wolverine stack and make him glow.'

⚠ Safety first — read this before anything else on this page

Approval status: No stack is FDA-approved, and this combination has never been tested in a human trial. FDA lists injectable GHK-Cu on its significant-safety-risk page. Blends are expressly outside the October 30, 2026 federal enforcement-discretion policy, which covers single ingredients only.

What has actually happened to people:

Copper toxicity is a real clinical entity, and GHK-Cu is a copper-delivery vehicle. The warning comes from inside the creator community: Dr. Froese names the escalation pattern directly — 'some is good, more must be better' meets a compound whose excess is genuinely toxic. See our page on GHK-Cu and copper toxicity.
Everything in the Wolverine record applies underneath: the blended-product FDA report (skin and gum darkening) and BPC-157's injection-site and breathing reports.

What nobody knows: Injectable GHK-Cu has no human trials, no dose-response data, and no copper-accumulation data. The three-way combination has never been studied at all. Topical cosmetic GHK-Cu history does not answer any of those questions.

Get medical care now if:

Nausea, abdominal pain, unusual fatigue, or yellowing skin/eyes — possible copper-overload territory; seek care and say what you have been taking.
Swelling of the lips or tongue, or trouble breathing, after an injection — call emergency services.
An injection site that worsens over days, or a lump appearing one to several weeks later — the delayed infection pattern; it needs a clinician.

Who should stay away: Anyone with Wilson disease or any copper-metabolism disorder — GHK-Cu delivers copper by design. Anyone with a cancer history (the Wolverine components' unresolved angiogenesis question). Minors, anyone pregnant, and tested athletes.

The product problem: A three-component blend triples the identity problem — every ingredient has to be what its label says, in one vial. Across all compounds, independent tester Finnrick Analytics finds roughly one in three gray-market samples fail basic expectations (February 2026).

Talk to a doctor who knows you are taking it. See our doctors directory. If you were harmed, report it to FDA MedWatch — your report is how the record gets built.

We don't publish doses, protocols, or sources — for any compound, ever. Our Legal Mandate.

Components

Wolverine + GHK-Cu — ’take the Wolverine stack and make him glow.'

What creators claim

Per Dr. Froese: GHK-Cu is a copper-delivery peptide — it carries copper into cells, where copper powers the enzymes that crosslink collagen and elastin; it signals breakdown of stiff, scar-like collagen and rebuilding with healthier fibers, and switches on repair-related genes while calming inflammation. Her trifecta framing: BPC-157 = blood supply, TB-500 = cell mobilization, GHK-Cu = structural remodel.

Evidence note

Everything said about Wolverine’s evidence applies, plus a copper peptide whose human data is largely cosmetic/topical. The three-way combination is untested. ‘Glow’ is a marketing word, not an outcome measure.

Dangers

This stack adds the signature danger of the whole family: copper toxicity from escalation — Froese’s own warning that ‘some is good, more must be better’ thinking meets a real toxicity. Full page: GHK-Cu & Copper Toxicity.

Legal note

Stacks and blends are not covered by the October 30, 2026 HHS enforcement-discretion policy (single-ingredient only). See Government & The Law.

Educational information only — not medical or legal advice. Status as of November 7, 2026. See Our Legal Mandate.

GLOW Stack

Components

What creators claim

Evidence note

Dangers

Legal note

Educational information only

Before you act on anything here

THE NETWORK — ONE PUBLISHER, EVERY FRONT